Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bone, R.
Right arrow Articles by Ursprung, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bone, R.
Right arrow Articles by Ursprung, J.

Chest, Vol 96, 849-851, Copyright © 1989 by American College of Chest Physicians


ARTICLES

An early test of survival in patients with the adult respiratory distress syndrome. The PaO2/FIo2 ratio and its differential response to conventional therapy. Prostaglandin E1 Study Group

RC Bone, R Maunder, G Slotman, H Silverman, TM Hyers, MD Kerstein and JJ Ursprung
Rush-Presbyterian St. Lukes Medical Center, Chicago.

Patients with established adult respiratory distress syndrome (ARDS) have a mortality rate that exceeds 50 percent. We analyzed the magnitude of hypoxemia as manifest by the PaO2/FIO2 ratio and its early response to conventional therapy including positive end-expiratory pressure (PEEP) in the placebo group of a large multicenter study. The PaO2/FIO2 ratio was not different at the time of diagnosis of ARDS in those patients who lived compared to those who subsequently died. After one day of conventional therapy including PEEP, those patients who survived increased their PaO2/FIO2 ratio. The nonsurvivors did not improve over a seven-day course. The difference in the PaO2/FIO2 ratio was significant throughout the seven-day observation period. We conclude that the early response to conventional therapy picks a patient population with a good prognosis and can be used as a test of likely survival from ARDS.


This article has been cited by other articles:


Home page
ChestHome page
M. F. El-Khatib and G. W. Jamaleddine
A New Oxygenation Index for Reflecting Intrapulmonary Shunting in Patients Undergoing Open-Heart Surgery
Chest, February 1, 2004; 125(2): 592 - 596.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. W. K. Lew, T.-K. Kwek, D. Tai, A. Earnest, S. Loo, K. Singh, K. M. Kwan, Y. Chan, C. F. Yim, S. L. Bek, et al.
Acute Respiratory Distress Syndrome in Critically Ill Patients With Severe Acute Respiratory Syndrome
JAMA, July 16, 2003; 290(3): 374 - 380.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J.-L. Vincent, S. Akca, A. de Mendonca, P. Haji-Michael, C. Sprung, R. Moreno, M. Antonelli, and P. M. Suter
The Epidemiology of Acute Respiratory Failure in Critically Ill Patients*
Chest, May 1, 2002; 121(5): 1602 - 1609.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. J. Nuckton, J. A. Alonso, R. H. Kallet, B. M. Daniel, J.-F. Pittet, M. D. Eisner, and M. A. Matthay
Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome
N. Engl. J. Med., April 25, 2002; 346(17): 1281 - 1286.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. El-Solh, P. Sikka, E. Bozkanat, W. Jaafar, and J. Davies
Morbid Obesity in the Medical ICU
Chest, December 1, 2001; 120(6): 1989 - 1997.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. B. Zwischenberger, S. K. Alpard, W. Tao, D. J. Deyo, and A. Bidani
Percutaneous extracorporeal arteriovenous carbon dioxide removal improves survival in respiratory distress syndrome: A prospective randomized outcomes study in adult sheep
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 542 - 551.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. R. Goodman, R. Fumagalli, P. Tagliabue, M. Tagliabue, M. Ferrario, L. Gattinoni, and A. Pesenti
Adult Respiratory Distress Syndrome Due to Pulmonary and Extrapulmonary Causes: CT, Clinical, and Functional Correlations
Radiology, November 1, 1999; 213(2): 545 - 552.
[Abstract] [Full Text]


Home page
ChestHome page
L. D. Hudson and K. P. Steinberg
Epidemiology of Acute Lung Injury and ARDS
Chest, July 1, 1999; 116(2007): 74S - 82S.
[Full Text]


Home page
NEJMHome page
A. P. Wheeler and G. R. Bernard
Treating Patients with Severe Sepsis
N. Engl. J. Med., January 21, 1999; 340(3): 207 - 214.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. UMBERTO MEDURI, E. A. TOLLEY, A. CHINN, F. STENTZ, and A. POSTLETHWAITE
Procollagen Types I and III Aminoterminal Propeptide Levels during Acute Respiratory Distress Syndrome and in Response to Methylprednisolone Treatment
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1432 - 1441.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. MONCHI, F. BELLENFANT, A. CARIOU, L.-M. JOLY, D. THEBERT, I. LAURENT, J.-F. DHAINAUT, and F. BRUNET
Early Predictive Factors of Survival in the Acute Respiratory Distress Syndrome . A Multivariate Analysis
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1076 - 1081.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. U. Meduri, A. S. Headley, E. Golden, S. J. Carson, R. A. Umberger, T. Kelso, and E. A. Tolley
Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
JAMA, July 8, 1998; 280(2): 159 - 165.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. ARTIGAS, G. R. BERNARD, J. CARLET, D. DREYFUSS, L. GATTINONI, L. HUDSON, M. LAMY, J. J. MARINI, M. A. MATTHAY, M. R. PINSKY, et al.
The American-European Consensus Conference on ARDS, Part 2 . Ventilatory, Pharmacologic, Supportive Therapy, Study Design Strategies, and Issues Related to Recovery and Remodeling
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1332 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Uchiba, K. Okajima, K. Murakami, M. Johno, M. Mohri, H. Okabe, and K. Takatsuki
rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation
Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L889 - L894.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. H. Kollef and D. P. Schuster
The Acute Respiratory Distress Syndrome
N. Engl. J. Med., January 5, 1995; 332(1): 27 - 37.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Chest Physicians.